Cuvrior Interactions
There are 46 drugs known to interact with Cuvrior (trientine), along with 1 disease interaction, and 2 alcohol/food interactions. Of the total drug interactions, 42 are moderate, and 4 are minor.
- View all 46 medications that may interact with Cuvrior
- View Cuvrior alcohol/food interactions (2)
- View Cuvrior disease interactions (1)
Most frequently checked interactions
View interaction reports for Cuvrior (trientine) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall XR (amphetamine / dextroamphetamine)
- Adzynma (apadamtase alfa, recombinant)
- ambrisentan
- Amondys 45 (casimersen)
- apremilast
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- Bylvay (odevixibat)
- Cabenuva (cabotegravir / rilpivirine)
- Cablivi (caplacizumab)
- Camzyos (mavacamten)
- Caplyta (lumateperone)
- cetirizine
- Cinqair (reslizumab)
- Complera (emtricitabine / rilpivirine / tenofovir)
- Cosentyx (secukinumab)
Cuvrior alcohol/food interactions
There are 2 alcohol/food interactions with Cuvrior (trientine).
Cuvrior disease interactions
There is 1 disease interaction with Cuvrior (trientine) which include:
Report options
QR code containing a link to this page
More about Cuvrior (trientine)
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: chelating agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
